全球定序試劑套件市場

預計到 2030 年全球定序試劑套件市場規模將達 192 億美元

全球定序試劑套件市場規模預計在2024年為129億美元，預計到2030年將達到192億美元，2024年至2030年的複合年成長率為6.9%。核酸萃取和擴增是本報告分析的細分市場之一，預計其複合年成長率為8.0%，到分析期結束時規模將達到125億美元。文庫製備細分市場在分析期間的複合年成長率預計為4.6%。

美國市場規模估計為 35 億美元，中國市場預計複合年成長率為 11.0%

美國定序試劑套件市場規模預計2024年達到35億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到40億美元，在2024-2030年的分析期間內，複合年成長率為11.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.3%和6.7%。在歐洲，預計德國市場的複合年成長率為4.5%。

全球「定序試劑套件」市場—主要趨勢與促進因素摘要

為什麼定序試劑套件對於基因組學和精準醫療至關重要？

定序試劑套件是 DNA 和 RNA 分析工作流程中的重要組成部分，提供製備、擴增和解碼遺傳物質所需的試劑和通訊協定。這些套件支援廣泛的應用，包括全基因組定序、標靶基因面板、表觀遺傳分析和總體基因體學。無論是在臨床診斷、腫瘤學研究或農業生物技術領域，研究試劑套件都能簡化複雜的工作流程並確保一致的結果。次世代定序儀(NGS) 的進步使這些套件變得更加重要，因為高通量平台需要高保真度、低污染的試劑才能有效處理數千個樣本。此外，隨著消費者基因組學、微生物組測試和感染疾病監測的興起，定序套件不僅在精英實驗室中得到應用，也在分散和照護現場環境中得到應用。它們的多功能性和在解鎖遺傳訊息方面的作用使它們在精準醫療時代至關重要。

文庫製備和 PCR 的創新會套件的發展嗎？

定序試劑套件已從基礎試劑包發展為複雜的酵素最佳化平台。文庫製備試劑套件的創新降低了輸入 DNA 要求，實現了自動化，並支持碎片化或劣化的樣本。無 PCR 工作流程可最大限度地減少擴增偏倚，雙索引接頭可在不影響準確性的情況下促進連接複用。酶的增強也縮短了反應時間，提高了特異性，並最大限度地降低了背景噪音。單細胞定序試劑套件、長讀定序試劑和甲基化特異性製備試劑套件正在將該技術的覆蓋範圍擴展到新的生物學領域。隨著研究人員尋求研究稀有變異、複雜的結構突變和細胞特異性表達模式，套件供應商正在以客製化的高性能化學品來應對。預填充卡盒、冷凍乾燥試劑和室溫穩定形式也便於處理和運輸，尤其是在現場診斷和移動實驗室環境中。

法規和臨床整合如何影響套件設計？

隨著定序擴展到受監管的臨床診斷領域，例如非侵入性產前檢測 (NIPT)、腫瘤伴隨診斷和病原體基因組追蹤，定序試劑套件正在經歷更嚴格的標準化和檢驗。開發人員目前正在開發符合 FDA、CE-IVDR 和其他國家監管要求的 IVD 級套件。這包括預先檢驗的工作流程、可追溯性和試劑的批間一致性。套件與定序平台共同開發，以確保端到端相容性並減少工作流程錯誤。與實驗室資訊系統 (LIS) 和自動化液體處理器的整合對於 CLIA 認證和醫院實驗室也變得至關重要。此外，與報銷掛鉤的診斷方法正在促使開發人員提高效率並降低每個樣本的成本。這些臨床應用正在從研究工具轉變為醫療保健工作流程中關鍵的、可認證的組件，從而推動更高的製造標準、更好的技術支援以及對合規性文件的關注。

是什麼推動了全球定序試劑套件市場的成長？

全球定序試劑套件市場的成長受到多種因素的推動，包括基因組研究支出的增加、NGS 的臨床應用以及定序化學的創新。美國、中國、英國和中東的國家基因組研究舉措的擴展正在推動對高品質、具成本效益套件的需求。定序在腫瘤學、罕見疾病診斷和感染疾病監測（尤其是後 COVID）中的整合使得標準化和檢驗的套件對於臨床實驗室至關重要。學術機構、CRO 和製藥公司正在擴展其基於測序的發現計劃，需要一系列專用試劑組。同時，單細胞、長讀和空間定序的技術進步正在突破套件性能和特異性的極限。分散式檢查的擴展，特別是在獸醫、農業和環境基因組學領域，正在創造對現場就緒套件的新需求。隨著定序成為生物學、醫學和農業的核心支柱，支持它的套件生態系統也迅速擴大。

部分

類型（核酸萃取和擴增、文庫製備、對照）、技術（NGS、桑格）、應用（藥物研發、腫瘤學、生殖健康、感染疾病）、最終用途（製藥和生物技術、醫院和診斷實驗室、學術和研究、其他最終用途）

受訪公司範例（總合32家）

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline（a Meridian Bioscience company）
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN NV
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）預測公司競爭定位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Sequencing Kits Market to Reach US$19.2 Billion by 2030

The global market for Sequencing Kits estimated at US$12.9 Billion in the year 2024, is expected to reach US$19.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Nucleic Acid Extraction & Amplification, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Library Preparation segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.5 Billion While China is Forecast to Grow at 11.0% CAGR

The Sequencing Kits market in the U.S. is estimated at US$3.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.0 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global "Sequencing Kits" Market - Key Trends & Drivers Summarized

Why Are Sequencing Kits Central to Genomics and Precision Medicine?

Sequencing kits are essential components in DNA and RNA analysis workflows, providing the reagents and protocols needed to prepare, amplify, and decode genetic material. These kits support a wide range of applications including whole genome sequencing, targeted gene panels, epigenetic profiling, and metagenomics. Whether used in clinical diagnostics, oncology research, or agricultural biotechnology, sequencing kits streamline complex workflows and ensure consistent results. Advances in next-generation sequencing (NGS) have made these kits even more critical, as higher throughput platforms require high-fidelity, low-contamination reagents to process thousands of samples efficiently. Additionally, with the rise of consumer genomics, microbiome testing, and infectious disease surveillance, sequencing kits are now used not only in elite research labs but also in decentralized and point-of-care settings. Their versatility and role in unlocking genetic information make them indispensable in the era of precision medicine.

Are Innovations in Library Prep and PCR Driving Kit Evolution?

Sequencing kits have evolved beyond basic reagent bundles into sophisticated, enzyme-optimized platforms. Innovations in library preparation kits have reduced input DNA requirements, enabled automation, and supported fragmented or degraded samples. PCR-free workflows are now available to minimize amplification bias, while dual-index adapters enhance multiplexing without compromising accuracy. Enzyme enhancements have also reduced reaction times, increased specificity, and minimized background noise. Single-cell sequencing kits, long-read sequencing reagents, and methylation-specific prep kits are expanding the technology’s reach into new biological domains. As researchers seek to study rare variants, complex structural variations, and cell-specific expression patterns, kit providers are responding with tailored, high-performance chemistry. Pre-loaded cartridges, lyophilized reagents, and room-temperature-stable formats are also enabling easier handling and shipping, especially in field diagnostics and mobile lab environments.

How Are Regulation and Clinical Integration Reshaping Kit Design?

As sequencing expands into regulated clinical diagnostics-such as non-invasive prenatal testing (NIPT), oncology companion diagnostics, and pathogen genome tracing-sequencing kits are undergoing stricter standardization and validation. Manufacturers are now developing IVD-grade kits compliant with FDA, CE-IVDR, and other national regulatory requirements. This includes pre-validated workflows, traceability, and lot-to-lot consistency in reagents. Kits are being co-developed with sequencing platforms to ensure end-to-end compatibility and reduce workflow errors. Integration with laboratory information systems (LIS) and automated liquid handlers is also becoming critical for CLIA-certified and hospital-based labs. Furthermore, reimbursement-linked diagnostics are pressuring developers to improve efficiency and reduce cost per sample. These clinical applications are transforming sequencing kits from research tools into critical, certifiable components of medical workflows, prompting higher manufacturing standards, better technical support, and increased focus on compliance documentation.

What’s Fueling Global Growth in the Sequencing Kits Market?

The growth in the global sequencing kits market is driven by several factors including rising genomic research funding, clinical adoption of NGS, and innovations in sequencing chemistry. Expanding national genomics initiatives across the U.S., China, UK, and Middle East are generating bulk demand for high-quality, cost-efficient kits. The integration of sequencing in oncology, rare disease diagnosis, and infectious disease surveillance-particularly post-COVID-has made standardized, validated kits essential for clinical labs. Academic institutions, CROs, and pharma companies are scaling up sequencing-based discovery programs, requiring a range of specialized reagent kits. Meanwhile, technological advancements in single-cell, long-read, and spatial sequencing are pushing the limits of kit performance and specificity. Growth of decentralized testing, especially in veterinary, agricultural, and environmental genomics, is creating new demand for field-compatible kits. As sequencing becomes a core pillar of biology, medicine, and agriculture, the supporting kit ecosystem is expanding rapidly to keep pace.

SCOPE OF STUDY:

The report analyzes the Sequencing Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control); Technology (NGS, Sanger); Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases); End-Use (Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Agilent Technologies, Inc.
• ArcherDX, Inc.
• Beckman Coulter, Inc.
• BGI Genomics Co., Ltd.
• Bioline (a Meridian Bioscience company)
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Fluidigm Corporation
• Illumina, Inc.
• New England Biolabs, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer, Inc.
• Phase Genomics
• QIAGEN N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Zymergen Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Sequencing Kits - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Widespread Adoption of Precision Medicine and Genomics Propels Growth in Sequencing Kit Demand
  • Rapid Decline in NGS Costs Expands Access and Drives Use of Sequencing Kits Across Research and Clinical Settings
  • Increased Focus on Infectious Disease Surveillance and Pathogen Genotyping Strengthens Business Case for Rapid Kits
  • Surge in Genetic Testing for Ancestry and Wellness Drives Consumer-Focused Sequencing Kit Innovations
  • Advancements in Single-Cell Sequencing Technologies Accelerate Need for High-Fidelity, Low-Input Kits
  • Regulatory Push for Companion Diagnostics and Targeted Therapies Expands Market for Clinical-Grade Sequencing Kits
  • Growing Cancer Genomics Programs Globally Spurs Demand for Oncology-Specific Sequencing Solutions
  • Automation in Laboratory Workflows Drives Adoption of Pre-Configured and Ready-to-Use Sequencing Kits
  • Expansion of Biobanking and Population Genomics Initiatives Creates New Opportunities for Large-Scale Sequencing
  • Rise in Agricultural Genomics and CRISPR Research Sustains Demand for High-Throughput Sequencing Kits
  • Strategic Collaborations Between Biotech and Diagnostic Companies Generate Pipeline for Custom Sequencing Kits
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Sequencing Kits Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Sequencing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Nucleic Acid Extraction & Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Nucleic Acid Extraction & Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Pharmaceutical & Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Pharmaceutical & Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for NGS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for NGS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Sanger by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Sanger by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Reproductive Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Reproductive Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• JAPAN
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Japan 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• CHINA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: China 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• EUROPE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Sequencing Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• FRANCE
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: France 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• GERMANY
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Germany 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Italy 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: UK 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Spain 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Russia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Sequencing Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Australia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• INDIA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: India 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: South Korea 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Sequencing Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Argentina 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Brazil 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Mexico 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Sequencing Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Sequencing Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Iran 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Israel 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: UAE 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030
• AFRICA
  • Sequencing Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Sequencing Kits by Type - Nucleic Acid Extraction & Amplification, Library Preparation and Control Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Sequencing Kits by Type - Percentage Breakdown of Value Sales for Nucleic Acid Extraction & Amplification, Library Preparation and Control for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Sequencing Kits by End-Use - Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Sequencing Kits by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology, Hospital & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Technology - NGS and Sanger - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Sequencing Kits by Technology - NGS and Sanger Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Sequencing Kits by Technology - Percentage Breakdown of Value Sales for NGS and Sanger for the Years 2015, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Sequencing Kits by Application - Drug Discovery, Oncology, Reproductive Health and Infectious Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Africa 15-Year Perspective for Sequencing Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery, Oncology, Reproductive Health and Infectious Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION